{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T07:46:50Z","timestamp":1791704810418,"version":"4.3.4"},"reference-count":6,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.tranon.2026.103038","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T19:32:12Z","timestamp":1789241532000},"page":"103038","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Salvage therapy for radiorecurrent prostate cancer: beyond equipoise \u2013 a call for biomarker-driven stratification"],"prefix":"10.1016","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-3582-3824","authenticated-orcid":false,"given":"Qing-Hua","family":"Ke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Qiong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.tranon.2026.103038_bib0001","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1001\/jamaoncol.2025.6448","article-title":"Salvage focal therapy vs radical prostatectomy for localized radiorecurrent prostate cancer","volume":"12","author":"Light","year":"2026","journal-title":"JAMa Oncol."},{"issue":"4","key":"10.1016\/j.tranon.2026.103038_bib0002","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1001\/jamaoncol.2025.6079","article-title":"Redefining salvage therapy for localized radiorecurrent prostate cancer\u2014in more ways than one","volume":"12","author":"Nikitas","year":"2026","journal-title":"JAMa Oncol."},{"issue":"3","key":"10.1016\/j.tranon.2026.103038_bib0003","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.eururo.2021.12.012","article-title":"Patterns of failure following external beam radiotherapy with or without an additional focal boost in the randomized controlled FLAME trial for localized prostate cancer","volume":"82","author":"Groen","year":"2022","journal-title":"Eur. Urol."},{"issue":"6","key":"10.1016\/j.tranon.2026.103038_bib0004","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/jamaoncol.2019.0096","article-title":"Assessment of 68Ga-PSMA-11 PET accuracy in localizing recurrent prostate cancer: a prospective single-arm clinical trial","volume":"5","author":"Fendler","year":"2019","journal-title":"JAMa Oncol."},{"issue":"3","key":"10.1016\/j.tranon.2026.103038_bib0005","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.eururo.2020.11.010","article-title":"A systematic review and meta-analysis of local salvage therapies after radiotherapy for prostate cancer (MASTER)","volume":"80","author":"Valle","year":"2021","journal-title":"Eur. Urol."},{"issue":"4","key":"10.1016\/j.tranon.2026.103038_bib0006","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.ijrobp.2019.07.012","article-title":"Salvage stereotactic body radiation therapy for local prostate cancer recurrence after radiation therapy: a retrospective multicenter study of the GETUG","volume":"105","author":"Pasquier","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326003748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326003748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T07:28:06Z","timestamp":1791703686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523326003748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":6,"alternative-id":["S1936523326003748"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2026.103038","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Salvage therapy for radiorecurrent prostate cancer: beyond equipoise \u2013 a call for biomarker-driven stratification","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2026.103038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103038"}}